Kure Health has introduced Kaqun Oxygen Immersion Therapy in Downtown Los Angeles, targeting cellular hypoxia linked to fatigue, inflammation, and slow recovery through physician-supervised, signal-based diagnostic protocols.
-- Kure Health has introduced Kaqun Oxygen Immersion Therapy as a therapeutic solution for cellular hypoxia at its center in Downtown Los Angeles, where it operates under an exclusive Western Hemisphere license for Kaqun technology. The latest offering targets individuals experiencing fatigue, inflammation, or slow recovery linked to poor cellular oxygenation common in patients with underlying disease.
More information is available at https://kurehealth.io/kaqun
Cellular hypoxia refers to insufficient oxygen delivery at the tissue level, a condition that underlies a range of chronic complaints. This oxygen shortfall contributes to downstream issues including slow wound healing, ongoing inflammation, cognitive decline, and accelerated aging; addressing the deficit at the cellular level, rather than managing individual symptoms, forms the basis for the new therapy, Kure Health explains.
The therapy delivers oxygen through Kaqun water, branded by Kure Health as KureO2. The company states that this water maintains a dissolved-oxygen partial pressure of 400 to 500 mmHg, roughly 10 to 15 times higher than ordinary water, and that unlike gas-bubbled oxygenated water products, which lose their oxygen content within minutes, KureO2 stays stabilized long enough to make transdermal absorption through the skin possible.
Individual treatment sessions are comprised of a 50-minute full-body immersion in water heated to 36 to 38 degrees Celsius, conducted in one of 16 private O2 chambers at the Downtown Los Angeles center. The company describes the session as a physician-supervised transdermal oxygen intervention rather than a spa treatment, distinguishing it from standalone Kaqun bath offerings elsewhere.
Rather than standing alone, Kaqun Oxygen Immersion Therapy is built into Kure Health's Signal-Based Medicine diagnostic framework, alongside IV nutrient infusions, AgeCode biological age testing, and KureSync cardiovascular analysis. Together, these tools generate a unique signal pattern for each patient, which physicians use to form the basis of a personalized treatment plan.
The Downtown Los Angeles center accepts new patients seeking an initial signal-based assessment to determine whether the therapy fits their biological profile. For those pursuing wellness and cellular optimization strategies, particularly those dealing with chronic fatigue, inflammation, or slow recovery, the new therapy provides a non-invasive option grounded in measurable oxygen data rather than general wellness claims.
Additional details on Kure Health's Signal-Based Medicine approach and the full KureO2 platform are available at https://kurecare.io
Contact Info:
Name: Kenton Gray
Email: Send Email
Organization: Kure Health or KureOS
Address: 621 S. Spring St. , Los Angeles , CA 90014, United States
Phone: +1-818-858-5551
Website: https://kurecare.health/
Source: PressCable
Release ID: 89204041
If there are any errors, inconsistencies, or queries arising from the content contained within this press release that require attention or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our reliable team will be available to promptly respond within 8 hours, taking proactive measures to rectify any identified issues or providing guidance on the removal process. Ensuring accurate and dependable information is our top priority.
